Quantum BioPharma
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
55 University Ave Suite 1003, Toronto, O...Phone Number
(833) 571-1811Website
www.quantumbiopharma.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Quantum BioPharma
Quantum BioPharma Ltd. is a biopharmaceutical company that researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its mission is to develop novel solutions for brain and inflammatory disorders. It aims to be a world class innovation driven biopharmaceutical company to improve the quality of life of patients.Explore more
Quantum BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Quantum BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Quantum BioPharma recently announced quarterly report
Check out if Quantum BioPharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Quantum BioPharma
Funding: Get notified immidiatlly once Quantum BioPharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Quantum BioPharma launches new products
Click to see if Quantum BioPharma had a recent Job posting/layoffs
Quantum BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Quantum BioPharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Quantum BioPharma
Find more new buyers
Company Profile Activity
Activity Insights
Quantum BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Quantum BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Quantum BioPharma.
Quantum BioPharma financials insights
Gather financial insights about Quantum BioPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Share Placement
$5M
Most Recent Scoops
Person-Based
Spending/Investment, Finance, Financial Operations
Person-Based
Clinical Operations, Finance, Financial Operations
Person-Based
Spending/Investment, Finance, Financial Operations
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Pharmaceuticals, Clinical Operations
Quantum BioPharma News & Media
NetworkNewsAudio Announces Audio Press Release (APR) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating ‘Rare Moment’ in MS Research
AUSTIN, Texas, Sept. 14, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach,” featuring Quantum BioPharma Ltd. (NASDAQ: QNTM).Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Quantum BioPharma
Sign Up For FreeTo access detailed company insights
Quantum BioPharma Ltd. is a biopharmaceutical company that researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its mission is to develop novel solutions for b... Read More
